Pharma 101 - Pharmaceutical Fraud
Eli Lilly and Company in More Hot Water
Montana is the latest state to sue Eli Lilly and Company, alleging that the company improperly and fraudulently marketed Zyprexa, an antipsychotic drug for unapproved uses. According to Montana Attorney General Mike McGrath, Eli Lilly improperly promoted Zyprexa for off label use and illegally paid kickbacks to physicians. Lilly created a sales force of 280 persons according to the State of Montana complaint, “to promote Zyprexa exclusively for off-label uses, specifically for long-term-care facilities to maximize off-label use of Zyprexa sales.” Under federal laws, pharmaceutical companies are prohibited from marketing their drugs for off-label or unapproved uses. Lilly’s worldwide sales of Zyprexa were $4.36 billion in 2006.
To read more click here.
| Posted By Marcella Auerbach | |
| Category Pharmaceutical | Posted May 17th, 2007 |
| Bookmark | |
2 Responses to “Eli Lilly and Company in More Hot Water”
Leave a Reply
Regulatory Documents (PDF)
- OIG Compliance Program Guidance for Pharmaceutical Manufacturers
- Medicaid Rebate Applicability of Physician Administered Drugs
Nolan Law Firm Articles
- Pages
- Categories
- Clinical Trials (2)
- Legal (36)
- Medicare (4)
- Off-Label (2)
- Pharmaceutical (2)
- Feeds
- Archives
Nolan & Auerbach, P.A. is a qui tam law firm whose practice is uniquely limited to healthcare fraud cases under the qui tam provisions of the False Claims Act. We know healthcare fraud because that's what we do! Toll free: 800-FRAUD 04
"The hiring of a lawyer is an important decision that should not be based
solely on advertisements. Before you decide, ask us to send you free written
information about our qualifications and experience."
Licensed in Florida
Located in Fort Lauderdale, Florida
Available for National Cases
May 17th, 2007 at 1:37 pm
Zyprexa promotion
Eli Lilly makes billions on diabetes treatment and also gets $4.2 billion a year in sales of their biggest cash cow Zyprexa which has been scandalized as *causing* diabetes as a major side effect.
Zyprexa off label promotion scandal is all over the news now.
Lilly drug reps are alleged to have called their marketing ploy,”Viva zyprexa”.
There are now 7 states (and counting) going after Lilly for fraud and restitution.
Daniel Haszard
July 29th, 2008 at 8:39 am
You’ve gotta wonder why the doctors taking the kickbacks are not prosecuted. Certainly we are not relying on drug reps to prescribe . . . .maybe we should be licensing them instead of the doctors.